Granting of Requests for Early Termination of the Waiting Period Under the Premerger Notification Rules, 36855-36857 [2020-13109]
Download as PDF
Federal Register / Vol. 85, No. 118 / Thursday, June 18, 2020 / Notices
of adding 1–BP to the CAA section
112(b)(1) HAP list.
V. Statutory and Executive Order
Review
Additional information about this
Executive Order can be found at https://
www.epa.gov/laws-regulations/lawsand-executive-orders.
A. Executive Order 12866: Regulatory
Planning and Review and Executive
Order 13563: Improving Regulation and
Regulatory Review
This action is a significant regulatory
action that was submitted to the Office
of Management and Budget (OMB) for
review because it raises novel legal or
policy issues. Any changes made in
response to OMB recommendations
have been documented in the docket.
Andrew Wheeler,
Administrator.
[FR Doc. 2020–13145 Filed 6–17–20; 8:45 am]
BILLING CODE 6560–50–P
FARM CREDIT SYSTEM INSURANCE
CORPORATION
Regular Meeting; Farm Credit System
Insurance Corporation Board
Farm Credit System Insurance
Corporation.
ACTION: Notice, regular meeting.
AGENCY:
Notice is hereby given, in
accordance with the provisions of
Article VI of the Bylaws of the Farm
Credit System Insurance Corporation
(FCSIC), that a regular meeting of the
Board of Directors of FCSIC will be held
June 25, 2020, at 10 a.m. EDT, until
such time as the Board may conclude its
business. Note: Because of the COVID–
19 pandemic, we will conduct the board
meeting virtually. If you would like to
observe the open portion of the virtual
meeting, see instructions below for
board meeting visitors.
Attendance: To observe the open
portion of the virtual meeting, go to
FCSIC.gov, select ‘‘News & Events,’’
then ‘‘Board Meetings.’’ There you will
find a description of the meeting and
‘‘Instructions for board meeting
visitors.’’ See SUPPLEMENTARY
SUMMARY:
INFORMATION for further information
about attendance requests.
FOR FURTHER INFORMATION CONTACT: Dale
Aultman, Secretary to the Board of the
Farm Credit System Insurance
Corporation (703) 883–4009. TTY is
(703) 883–4056.
SUPPLEMENTARY INFORMATION: Parts of
this meeting of the Board will be open
to the public, and parts will be closed.
If you wish to observe the open portion,
follow the instructions above in the
‘‘Attendance’’ section at least 24 hours
before the meeting. Please note that this
meeting begins at 10:00 a.m. EDT with
a session that is closed to the public.
You may join this meeting at 11:15 a.m.
EDT. We will begin the open session
promptly at 11:30 a.m. EDT.
Assistance: If you need assistance for
accessibility reasons or if you have any
questions, contact Dale Aultman,
Secretary to the Farm Credit
Administration Board, at (703) 883–
4009. The matters to be considered at
the meeting are as follows:
A. Closed Session—Risk Management
Reports
• FCSIC Report on Insurance Risk/
Premium Risk Factors
B. Open Session
Approval of Minutes
• March 12, 2020
C. Quarterly Business Reports
• FCSIC Financial Report
• Report on Insured Obligations
• Report on Annual Performance Plan
D. New Business
• Mid-Year Review of Insurance
Premium Rates
Dated: June 15, 2020.
Dale Aultman,
Secretary, Farm Credit System Insurance
Corporation.
[FR Doc. 2020–13178 Filed 6–17–20; 8:45 am]
BILLING CODE 6705–01–P
FEDERAL ELECTION COMMISSION
Sunshine Act Meeting
Tuesday, June 23, 2020
at 10:00 a.m. and its continuation on
June 25, 2020 at 10:00 a.m.
TIME AND DATE:
1050 First Street NE,
Washington, DC (This meeting will be a
virtual meeting).
STATUS: This meeting will be closed to
the public.
MATTERS TO BE CONSIDERED: Compliance
matters pursuant to 52 U.S.C. 30109.
Matters concerning participation in civil
actions or proceedings or arbitration.
*
*
*
*
*
CONTACT PERSON FOR MORE INFORMATION:
Judith Ingram, Press Officer; Telephone:
(202) 694–1220.
PLACE:
Vicktoria J. Allen,
Acting Deputy Secretary of the Commission.
[FR Doc. 2020–13303 Filed 6–16–20; 4:15 pm]
BILLING CODE 6715–01–P
FEDERAL TRADE COMMISSION
Granting of Requests for Early
Termination of the Waiting Period
Under the Premerger Notification
Rules
Section 7A of the Clayton Act, 15
U.S.C. 18a, as added by Title II of the
Hart-Scott-Rodino Antitrust
Improvements Act of 1976, requires
persons contemplating certain mergers
or acquisitions to give the Federal Trade
Commission and the Assistant Attorney
General advance notice and to wait
designated periods before
consummation of such plans. Section
7A(b)(2) of the Act permits the agencies,
in individual cases, to terminate this
waiting period prior to its expiration
and requires that notice of this action be
published in the Federal Register.
The following transactions were
granted early termination—on the dates
indicated—of the waiting period
provided by law and the premerger
notification rules. The listing for each
transaction includes the transaction
number and the parties to the
transaction. The grants were made by
the Federal Trade Commission and the
Assistant Attorney General for the
Antitrust Division of the Department of
Justice. Neither agency intends to take
any action with respect to these
proposed acquisitions during the
applicable waiting period.
EARLY TERMINATIONS GRANTED MAY 1, 2020 THRU MAY 31, 2020
05/01/2020
20201000 ......
G
The Carle Foundation; Advocate Aurora Health, Inc.; The Carle Foundation.
05/04/2020
20200999 ......
20201001 ......
VerDate Sep<11>2014
G
G
TPG Partners VIII, L.P.; LifeStance Health, LLC; TPG Partners VIII, L.P.
Quincy Health, LLC; Quorum Health Corp.; Quincy Health, LLC.
17:40 Jun 17, 2020
Jkt 250001
PO 00000
Frm 00028
Fmt 4703
Sfmt 4703
36855
E:\FR\FM\18JNN1.SGM
18JNN1
36856
Federal Register / Vol. 85, No. 118 / Thursday, June 18, 2020 / Notices
EARLY TERMINATIONS GRANTED MAY 1, 2020 THRU MAY 31, 2020—Continued
20201002
20201003
20201005
20201006
......
......
......
......
G
G
G
G
Mr. Len Blavatnik; DigitalOcean Holdings, Inc.; Mr. Len Blavatnik.
Reyes Holdings, L.L.C.; Thomas J. Louderback; Reyes Holdings, L.L.C.
Providence Equity Partners VIII L.P.; OUTFRONT Media Inc.; Providence Equity Partners VIII L.P.
Ares Special Opportunities Fund (Offshore), L.P.; OUTFRONT Media Inc.; Ares Special Opportunities Fund (Offshore),
L.P.
05/05/2020
20191732 ......
S
AbbVie Inc.; Allergan plc; AbbVie Inc.
05/06/2020
20200992 ......
20201008 ......
G
G
Starwood Opportunity Fund XI Global, L.P.; Extended Stay America, Inc.; Starwood Opportunity Fund XI Global, L.P.
ProAssurance Corporation; Norcal Mutual Insurance Company; ProAssurance Corporation.
05/11/2020
20201012
20201013
20201014
20201016
20201023
20201024
......
......
......
......
......
......
G
G
G
G
G
G
IIF US Holding LP; Xcel Energy Inc.; IIF US Holding LP.
Eros International plc; STX Filmworks, Inc.; Eros International plc.
Artur Bergman; Fastly, Inc.; Artur Bergman.
Turning Point Brands, Inc.; Standard General Offshore Fund Ltd.; Turning Point Brands, Inc.
KKR Americas Fund XII, L.P.; US Foods Holding Corp.; KKR Americas Fund XII, L.P.
Flexpoint Fund IV–A, L.P.; TigerRisk Partners LLC; Flexpoint Fund IV–A, L.P.
05/13/2020
20201025 ......
G
LS Power Equity Partners IV, L.P.; Siemens Aktiengesellschaft; LS Power Equity Partners IV, L.P.
05/14/2020
20201021 ......
G
Ingredion Incorporated; PureCircle Limited; Ingredion Incorporated.
05/19/2020
20201034 ......
20201035 ......
G
G
20201039 ......
20201042 ......
G
G
Wellspring Capital Partners VI, L.P.; Merit Mezzanine Fund VI, L.P.; Wellspring Capital Partners VI, L.P.
Cognizant Technology Solutions Corporation; William C. Ross, Jr. and Peri Ross; Cognizant Technology Solutions Corporation.
Nemo Investor Aggregator, Ltd.; OneSpaWorld Holdings Limited; Nemo Investor Aggregator, Ltd.
TPG Inertia Holdings, LP; Moshe Yanai; TPG Inertia Holdings, LP.
05/20/2020
20201036 ......
G
Adam D’Angelo; Quora, Inc.; Adam D’Angelo.
05/21/2020
20200939 ......
G
WillScot Corporation; Mobile Mini, Inc.; WillScot Corporation.
05/26/2020
20201040
20201044
20201045
20201050
20201053
20201054
20201056
20201061
20201063
......
......
......
......
......
......
......
......
......
G
G
G
G
G
G
G
G
G
GHO Capital Fund II LP; X-Co Holdings, LP; GHO Capital Fund II LP.
Royal Dutch Shell plc; National Fuel Gas Company; Royal Dutch Shell plc.
National Fuel Gas Company; Royal Dutch Shell plc; National Fuel Gas Company.
USI Advantage Corp.; Associated Banc-Corp.; USI Advantage Corp.
Aves IA Infrastructure Limited Partnership; Newco LLC; Aves IA Infrastructure Limited Partnership.
Aflac Incorporated; Zurich Insurance Group Ltd.; Aflac Incorporated.
Clayton, Dubilier & Rice Fund X, L.P.; Randal D. Boyd; Clayton, Dubilier & Rice Fund X, L.P.
Change Healthcare Inc.; National Health Coalition, Inc.; Change Healthcare Inc.
Lyndon Lea; Prism Data, LLC; Lyndon Lea.
05/27/2020
20201046 ......
20201047 ......
G
G
Halmont Properties Corporation; TerraForm Power NY Holdings, Inc.; Halmont Properties Corporation.
Brookfield Renewable Partners L.P.; TerraForm Power NY Holdings, Inc.; Brookfield Renewable Partners L.P.
FOR FURTHER INFORMATION CONTACT:
Theresa Kingsberry (202–326–3100),
VerDate Sep<11>2014
17:40 Jun 17, 2020
Jkt 250001
Program Support Specialist, Federal
Trade Commission Premerger
PO 00000
Frm 00029
Fmt 4703
Sfmt 4703
Notification Office, Bureau of
Competition, Room CC–5301,
Washington, DC 20024.
E:\FR\FM\18JNN1.SGM
18JNN1
Federal Register / Vol. 85, No. 118 / Thursday, June 18, 2020 / Notices
By direction of the Commission.
April J. Tabor,
Secretary.
[FR Doc. 2020–13109 Filed 6–17–20; 8:45 am]
BILLING CODE 6750–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2019–N–3077]
Agency Information Collection
Activities; Proposed Collection;
Comment Request; Obtaining
Information To Understand Challenges
and Opportunities Encountered by
Compounding Outsourcing Facilities
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA or Agency) is
announcing an opportunity for public
comment on the proposed collection of
certain information by the Agency.
Under the Paperwork Reduction Act of
1995 (PRA), Federal Agencies are
required to publish notice in the
Federal Register concerning each
proposed collection of information,
including each proposed extension of an
existing collection of information, and
to allow 60 days for public comment in
response to the notice. This notice
solicits comments on information
collection associated with FDA research
in obtaining information from
pharmacists and other management at
outsourcing facilities as well as at
related compounding businesses to
support a comprehensive analysis of the
outsourcing facility sector that will
inform ongoing FDA work in this area.
DATES: Submit either electronic or
written comments on the collection of
information by August 17, 2020.
ADDRESSES: You may submit comments
as follows. Please note that late,
untimely filed comments will not be
considered. Electronic comments must
be submitted on or before August 17,
2020. The https://www.regulations.gov
electronic filing system will accept
comments until 11:59 p.m. Eastern Time
at the end of August 17, 2020.
Comments received by mail/hand
delivery/courier (for written/paper
submissions) will be considered timely
if they are postmarked or the delivery
service acceptance receipt is on or
before that date.
SUMMARY:
Electronic Submissions
Submit electronic comments in the
following way:
VerDate Sep<11>2014
17:40 Jun 17, 2020
Jkt 250001
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
Comments submitted electronically,
including attachments, to https://
www.regulations.gov will be posted to
the docket unchanged. Because your
comment will be made public, you are
solely responsible for ensuring that your
comment does not include any
confidential information that you or a
third party may not wish to be posted,
such as medical information, your or
anyone else’s Social Security number, or
confidential business information, such
as a manufacturing process. Please note
that if you include your name, contact
information, or other information that
identifies you in the body of your
comments, that information will be
posted on https://www.regulations.gov.
• If you want to submit a comment
with confidential information that you
do not wish to be made available to the
public, submit the comment as a
written/paper submission and in the
manner detailed (see ‘‘Written/Paper
Submissions’’ and ‘‘Instructions’’).
Written/Paper Submissions
Submit written/paper submissions as
follows:
• Mail/Hand Delivery/Courier (for
written/paper submissions): Dockets
Management Staff (HFA–305), Food and
Drug Administration, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852.
• For written/paper comments
submitted to the Dockets Management
Staff, FDA will post your comment, as
well as any attachments, except for
information submitted, marked and
identified, as confidential, if submitted
as detailed in ‘‘Instructions.’’
Instructions: All submissions received
must include the Docket No. FDA–
2019–N–3077 for ‘‘Agency Information
Collection Activities; Obtaining
Information to Understand Challenges
and Opportunities Encountered by
Compounding Outsourcing Facilities.’’
Received comments, those filed in a
timely manner (see ADDRESSES), will be
placed in the docket and, except for
those submitted as ‘‘Confidential
Submissions,’’ publicly viewable at
https://www.regulations.gov or at the
Dockets Management Staff between 9
a.m. and 4 p.m., Monday through
Friday.
• Confidential Submissions—To
submit a comment with confidential
information that you do not wish to be
made publicly available, submit your
comments only as a written/paper
submission. You should submit two
copies total. One copy will include the
information you claim to be confidential
with a heading or cover note that states
PO 00000
Frm 00030
Fmt 4703
Sfmt 4703
36857
‘‘THIS DOCUMENT CONTAINS
CONFIDENTIAL INFORMATION.’’ The
Agency will review this copy, including
the claimed confidential information, in
its consideration of comments. The
second copy, which will have the
claimed confidential information
redacted/blacked out, will be available
for public viewing and posted on
https://www.regulations.gov. Submit
both copies to the Dockets Management
Staff. If you do not wish your name and
contact information to be made publicly
available, you can provide this
information on the cover sheet and not
in the body of your comments and you
must identify this information as
‘‘confidential.’’ Any information marked
as ‘‘confidential’’ will not be disclosed
except in accordance with 21 CFR 10.20
and other applicable disclosure law. For
more information about FDA’s posting
of comments to public dockets, see 80
FR 56469, September 18, 2015, or access
the information at: https://
www.govinfo.gov/content/pkg/FR-201509-18/pdf/2015-23389.pdf.
Docket: For access to the docket to
read background documents or the
electronic and written/paper comments
received, go to https://
www.regulations.gov and insert the
docket number, found in brackets in the
heading of this document, into the
‘‘Search’’ box and follow the prompts
and/or go to the Dockets Management
Staff, 5630 Fishers Lane, Rm. 1061,
Rockville, MD 20852.
Ila
S. Mizrachi, Office of Operations, Food
and Drug Administration, Three White
Flint North, 10A–12M, 11601
Landsdown St., North Bethesda, MD
20852, 301–796–7726, PRAStaff@
fda.hhs.gov.
FOR FURTHER INFORMATION CONTACT:
Under the
PRA (44 U.S.C. 3501–3521), Federal
Agencies must obtain approval from the
Office of Management and Budget
(OMB) for each collection of
information they conduct or sponsor.
‘‘Collection of information’’ is defined
in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes Agency requests
or requirements that members of the
public submit reports, keep records, or
provide information to a third party.
Section 3506(c)(2)(A) of the PRA (44
U.S.C. 3506(c)(2)(A)) requires Federal
Agencies to provide a 60-day notice in
the Federal Register concerning each
proposed collection of information,
including each proposed extension of an
existing collection of information,
before submitting the collection to OMB
for approval. To comply with this
requirement, FDA is publishing notice
SUPPLEMENTARY INFORMATION:
E:\FR\FM\18JNN1.SGM
18JNN1
Agencies
[Federal Register Volume 85, Number 118 (Thursday, June 18, 2020)]
[Notices]
[Pages 36855-36857]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-13109]
=======================================================================
-----------------------------------------------------------------------
FEDERAL TRADE COMMISSION
Granting of Requests for Early Termination of the Waiting Period
Under the Premerger Notification Rules
Section 7A of the Clayton Act, 15 U.S.C. 18a, as added by Title II
of the Hart-Scott-Rodino Antitrust Improvements Act of 1976, requires
persons contemplating certain mergers or acquisitions to give the
Federal Trade Commission and the Assistant Attorney General advance
notice and to wait designated periods before consummation of such
plans. Section 7A(b)(2) of the Act permits the agencies, in individual
cases, to terminate this waiting period prior to its expiration and
requires that notice of this action be published in the Federal
Register.
The following transactions were granted early termination--on the
dates indicated--of the waiting period provided by law and the
premerger notification rules. The listing for each transaction includes
the transaction number and the parties to the transaction. The grants
were made by the Federal Trade Commission and the Assistant Attorney
General for the Antitrust Division of the Department of Justice.
Neither agency intends to take any action with respect to these
proposed acquisitions during the applicable waiting period.
Early Terminations Granted May 1, 2020 Thru May 31, 2020
------------------------------------------------------------------------
------------------------------------------------------------------------
05/01/2020
------------------------------------------------------------------------
20201000........... G The Carle Foundation; Advocate Aurora
Health, Inc.; The Carle Foundation.
------------------------------------------------------------------------
05/04/2020
------------------------------------------------------------------------
20200999........... G TPG Partners VIII, L.P.; LifeStance
Health, LLC; TPG Partners VIII, L.P.
20201001........... G Quincy Health, LLC; Quorum Health Corp.;
Quincy Health, LLC.
[[Page 36856]]
20201002........... G Mr. Len Blavatnik; DigitalOcean Holdings,
Inc.; Mr. Len Blavatnik.
20201003........... G Reyes Holdings, L.L.C.; Thomas J.
Louderback; Reyes Holdings, L.L.C.
20201005........... G Providence Equity Partners VIII L.P.;
OUTFRONT Media Inc.; Providence Equity
Partners VIII L.P.
20201006........... G Ares Special Opportunities Fund
(Offshore), L.P.; OUTFRONT Media Inc.;
Ares Special Opportunities Fund
(Offshore), L.P.
------------------------------------------------------------------------
05/05/2020
------------------------------------------------------------------------
20191732........... S AbbVie Inc.; Allergan plc; AbbVie Inc.
------------------------------------------------------------------------
05/06/2020
------------------------------------------------------------------------
20200992........... G Starwood Opportunity Fund XI Global, L.P.;
Extended Stay America, Inc.; Starwood
Opportunity Fund XI Global, L.P.
20201008........... G ProAssurance Corporation; Norcal Mutual
Insurance Company; ProAssurance
Corporation.
------------------------------------------------------------------------
05/11/2020
------------------------------------------------------------------------
20201012........... G IIF US Holding LP; Xcel Energy Inc.; IIF
US Holding LP.
20201013........... G Eros International plc; STX Filmworks,
Inc.; Eros International plc.
20201014........... G Artur Bergman; Fastly, Inc.; Artur
Bergman.
20201016........... G Turning Point Brands, Inc.; Standard
General Offshore Fund Ltd.; Turning Point
Brands, Inc.
20201023........... G KKR Americas Fund XII, L.P.; US Foods
Holding Corp.; KKR Americas Fund XII,
L.P.
20201024........... G Flexpoint Fund IV-A, L.P.; TigerRisk
Partners LLC; Flexpoint Fund IV-A, L.P.
------------------------------------------------------------------------
05/13/2020
------------------------------------------------------------------------
20201025........... G LS Power Equity Partners IV, L.P.; Siemens
Aktiengesellschaft; LS Power Equity
Partners IV, L.P.
------------------------------------------------------------------------
05/14/2020
------------------------------------------------------------------------
20201021........... G Ingredion Incorporated; PureCircle
Limited; Ingredion Incorporated.
------------------------------------------------------------------------
05/19/2020
------------------------------------------------------------------------
20201034........... G Wellspring Capital Partners VI, L.P.;
Merit Mezzanine Fund VI, L.P.; Wellspring
Capital Partners VI, L.P.
20201035........... G Cognizant Technology Solutions
Corporation; William C. Ross, Jr. and
Peri Ross; Cognizant Technology Solutions
Corporation.
20201039........... G Nemo Investor Aggregator, Ltd.;
OneSpaWorld Holdings Limited; Nemo
Investor Aggregator, Ltd.
20201042........... G TPG Inertia Holdings, LP; Moshe Yanai; TPG
Inertia Holdings, LP.
------------------------------------------------------------------------
05/20/2020
------------------------------------------------------------------------
20201036........... G Adam D'Angelo; Quora, Inc.; Adam D'Angelo.
------------------------------------------------------------------------
05/21/2020
------------------------------------------------------------------------
20200939........... G WillScot Corporation; Mobile Mini, Inc.;
WillScot Corporation.
------------------------------------------------------------------------
05/26/2020
------------------------------------------------------------------------
20201040........... G GHO Capital Fund II LP; X-Co Holdings, LP;
GHO Capital Fund II LP.
20201044........... G Royal Dutch Shell plc; National Fuel Gas
Company; Royal Dutch Shell plc.
20201045........... G National Fuel Gas Company; Royal Dutch
Shell plc; National Fuel Gas Company.
20201050........... G USI Advantage Corp.; Associated Banc-
Corp.; USI Advantage Corp.
20201053........... G Aves IA Infrastructure Limited
Partnership; Newco LLC; Aves IA
Infrastructure Limited Partnership.
20201054........... G Aflac Incorporated; Zurich Insurance Group
Ltd.; Aflac Incorporated.
20201056........... G Clayton, Dubilier & Rice Fund X, L.P.;
Randal D. Boyd; Clayton, Dubilier & Rice
Fund X, L.P.
20201061........... G Change Healthcare Inc.; National Health
Coalition, Inc.; Change Healthcare Inc.
20201063........... G Lyndon Lea; Prism Data, LLC; Lyndon Lea.
------------------------------------------------------------------------
05/27/2020
------------------------------------------------------------------------
20201046........... G Halmont Properties Corporation; TerraForm
Power NY Holdings, Inc.; Halmont
Properties Corporation.
20201047........... G Brookfield Renewable Partners L.P.;
TerraForm Power NY Holdings, Inc.;
Brookfield Renewable Partners L.P.
------------------------------------------------------------------------
FOR FURTHER INFORMATION CONTACT: Theresa Kingsberry (202-326-3100),
Program Support Specialist, Federal Trade Commission Premerger
Notification Office, Bureau of Competition, Room CC-5301, Washington,
DC 20024.
[[Page 36857]]
By direction of the Commission.
April J. Tabor,
Secretary.
[FR Doc. 2020-13109 Filed 6-17-20; 8:45 am]
BILLING CODE 6750-01-P